Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates.
Saved in:
| Title: | Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates. |
|---|---|
| Authors: | Dross S; Department of Microbiology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, Seattle, WA, United States., Venkataraman R; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA, United States., Patel S; Center for Cancer and Immunology Research, Children's National Hospital and Department of Pediatrics, The George Washington University, Washington, DC, United States., Huang ML; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States., Bollard CM; Center for Cancer and Immunology Research, Children's National Hospital and Department of Pediatrics, The George Washington University, Washington, DC, United States., Rosati M; Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, MD, United States., Pavlakis GN; Human Retrovirus Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, MD, United States., Felber BK; Human Retrovirus Pathogenesis Section, Vaccine Branch, National Cancer Institute at Frederick, Frederick, MD, United States., Bar KJ; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Shaw GM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Jerome KR; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.; Division of Vaccine and Infectious Diseases, Fred Hutchinson Cancer Center, Seattle, WA, United States., Mullins JI; Department of Microbiology, University of Washington, Seattle, WA, United States.; Department of Medicine, University of Washington, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States., Kiem HP; Washington National Primate Research Center, Seattle, WA, United States.; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.; Department of Medicine, University of Washington, Seattle, WA, United States., Fuller DH; Department of Microbiology, University of Washington, Seattle, WA, United States.; Washington National Primate Research Center, Seattle, WA, United States., Peterson CW; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Department of Medicine, University of Washington, Seattle, WA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2023 May 03; Vol. 14, pp. 1188018. Date of Electronic Publication: 2023 May 03 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
